Full Show: New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg
Dirk Hose, MD Anja Seckinger, MD Interview Date: May 24, 2017 Summary Many myeloma patients…
Browsing: Myeloma Crowd Radio
Our Next Show: Targeting BCMA and T Cells in New Bi-Specific Myeloma Antibody with Anja Seckinger, MD and Dirk Hose, MD, University of Heidelberg, Wednesday, May 24 @ 10 am Central
Wednesday, May 24, 2017 @ 8 am Pacific, 9 am Mountain, 10 am Central, 11…
Full Show: Studying MGUS and Smoldering Myeloma Genetics and Using Immunotherapies in High-Risk Smoldering Myeloma with Dr. Elisabet Manasanch, MD Anderson Cancer Center
Elisabet Manasanch, MD MD Anderson Cancer Center Interview Date: April 26, 2017 Summary MGUS and…
Our Next Show: What Predicts Progression of MGUS and Smoldering Myeloma? New Study and Smoldering Myeloma Therapies with Elisabet Manasanch, MD, MD Anderson Cancer Center, Wednesday, April 26 @ 2 pm Central
Wednesday, April 24, 2017 @ Noon Pacific, 1 pm Mountain, 2 pm Central, 3 pm…
Full Show: Myeloma Therapy Using Intraveneous Vitamin C with Dr. Guido Tricot, MD, PhD, University of Iowa
Guido Tricot, MD, PhD University of Iowa Interview Date: March 31, 2017 Summary In the…
Full Show: The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute
Gareth Morgan, MD, FRCP, FRCPath, PhD UAMS Myeloma Institute Interview Date: March 24, 2017 Summary…
Our Next Show: The Myeloma-Killing Effects of Intravenous Vitamin C with Dr. Guido Tricot, MD, PhD, University of Iowa, Friday, March 31 @ 2 pm Central
Friday, March 31, 2017 @ Noon Pacific, 1 pm Mountain, 2 pm Central, 3 pm…
Our Next Show: The Myeloma Genome Project with Dr. Gareth Morgan, UAMS Myeloma Institute, Friday, March 24 @ Noon Central
Friday, March 24, 2017 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm…
Full Show: Allogeneic Transplant for Young, High-Risk Myeloma Patients with Dr. Cristina Gasparetto, MD, Duke Medical Center
Cristina Gasparetto, MD Duke University Interview Date: February 17, 2017 Summary Allogeneic stem cell transplant…
Full Show: The Latest in Amyloidosis Research With Heather Landau, MD, Memorial Sloan Kettering Cancer Center
Heather Landau, MD Memorial Sloan Kettering Cancer Center Interview Date: February 28, 2017 Summary Many…
Our Next Show: Latest Treatments for Amyloidosis and Multiple Myeloma with Dr. Heather Landau, MD, MSKCC, Feb 28 @ 11 am Eastern
Tuesday, February 28, 2017 @ 8 am Pacific, 9 am Mountain, 10 am Central, 11…
Our Next Show: Allo Transplant for Young, High-Risk Myeloma Patients with Cristina Gasparetto, MD, Duke University, Friday, Feb 17 @ 1 pm Eastern
Friday, February 17, 2017 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm Eastern…
Full Show: Minimal Residual Disease Testing and Why It Matters to Myeloma Patients with Dr. Ola Landgren, MD, PhD, MSKCC
Ola C. Landgren, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: January 12, 2017…
Full Show: Myeloma Progress and Where We’re Headed Next with Robert Orlowski, MD, PhD, MD Anderson Cancer Center
Robert Z. Orlowski, MD, PhD MD Anderson Cancer Center Interview Date: January 5, 2017 Summary…
Our Next Show: MRD Testing in Myeloma with Dr. Ola Landgren, MSKCC, Thursday, Jan 12 @ 2 pm Eastern
Thursday, January 12, 2016 @ 11 am Pacific, Noon Mountain, 1 pm Central, 2 pm Eastern…
Full Show: Ask the Myeloma Experts – Patient Questions from the St. Louis Myeloma Crowd Round Table Meeting
Ask the Myeloma Experts Myeloma Crowd Round Table in St. Louis December 30, 2016 Summary…
Our Next Show: What’s New for Multiple Myeloma in 2017 with Dr. Robert Orlowski, MD, PhD, MD Anderson, Jan 5 @ 2 pm Central
Thursday, January 5, 2016 @ Noon Pacific, 1 pm Mountain, 2 pm Central, 3 pm…
Full Show: MCRI-Funded Project Update on MILs Immunotherapy for High Risk Myeloma with Dr. Ivan Borrello
Ivan Borrello, MD Johns Hopkins School of Medicine Interview Date: December, 2016 Summary The Myeloma…
Full Show: Personalized Medicine in Myeloma With Dr. Craig Cole, University of Michigan
Craig Cole, MD University of Michigan Interview Date: November 17, 2016 Summary How can doctors…
Full Show: Transplant “Plus” Options with Sergio Giralt, MD of Memorial Sloan Kettering Cancer Center
Sergio Giralt, MD Memorial Sloan Kettering Cancer Center Interview Date: November 11, 2016 Summary Stem…
Our Next Show: Personalized Medicine in Myeloma with Craig Cole, MD, University of Michigan, Thursday, Nov 17 @ 1 pm Eastern
Thursday, November 17, 2016 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm…
Our Next Show: Transplant “Plus” Strategies with Dr. Sergio Giralt, MD, MSKCC, Friday, Nov 11 @ 5 pm Eastern
Friday, November 11, 2016 @ 2 pm Pacific, 3 pm Mountain, 4 pm Central, 5…
Full Show: When It’s Too Late to Join a Clinical Trial and the New Drug Selinexor with Dr. Nikoletta Lendvai, MD, PhD, MKSCC
Nikoletta Lendvai, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: October 28, 2016 Summary…
Full Show: Best Up-Front Treatment for Newly Diagnosed Myeloma and What to Consider at Relapse with Dr. Andrzej Jakubowiak, MD, PhD
Andrzej Jakubowiak, MD, PhD University of Chicago Interview Date: October 19, 2016 Summary Newly diagnosed…
Our Next Show: Clinical Trials 101 and the New Myeloma Drug Selinexor with Nikoletta Lendvai, MD, PhD, MSKCC, Friday, Oct 28 @ 11 am Eastern
Friday, October 28, 8 am Pacific, 9 am Mountain, 10 am Central, 11 am Eastern…
Our Next Show: Most Effective Strategies for Newly Diagnosed Myeloma and Relapse with Andrzej Jakubowiak, MD, PhD, U of Chicago, Wednesday, October 19 @ 10 am Central
Wednesday, October 19, 8 am Pacific, 9 am Mountain, 10 am Central, 11 am Eastern…
Full Show: Daratumumab in Detail for Multiple Myeloma with Torben Plesner, MD, Vejle Hospital, Denmark
Torben Plesner, MD Vejle Hospital, Denmark Interview Date: September 28, 2016 Summary Dr. Plesner was…
Full Show: New Definitions and Treatments of MGUS and Smoldering Myeloma with Pioneer Robert Kyle, MD, Mayo Clinic
Robert Kyle, MD Mayo Clinic Rochester Interview Date: September 16, 2016 Summary Dr. Kyle shares…
Our Next Show: The Ins and Outs of Daratumumab for Myeloma Patients with Dr. Torben Plesner @ 9 am Eastern, Wednesday, Sept 28
Wednesday, September 28, 6 am Pacific, 7 am Mountain, 8 am Central, 9 am Eastern…
Full Show: MCRI Update on Car T Cell Update by Dr. Michael Hudecek, MD, University of Würzburg, Germany
Dr. Michael Hudecek, MD University of Würzburg, Germany Interview Date: August 24, 2016 Summary The…
Our Next Show: Forty Years of Data on MGUS and Smoldering Myeloma with Myeloma Pioneer Dr. Robert Kyle, MD, Mayo Clinic
Friday, September 16, 8 am Pacific, 9 am Mountain, 10 am Central, 11 am Eastern…
Full Show: Benefits of Up-Front Myeloma Transplant and Maintenance Therapy with Dr. Philip McCarthy, Roswell Park Cancer Institute
Dr. Philip McCarthy, MD Roswell Park Cancer Institute Interview Date: August 3, 2016 Summary Stem…
Our Next Show: MCRI Update on CAR T Cell Therapy with Dr. Michael Hudecek, University of Würzburg, Germany, Wed, August 24 @ 11 am Eastern
Wednesday, August 24, 8 am Pacific, 9 am Mountain, 10 am Central, 11 am Eastern…
Our Next Show: Making Stem Cell Transplant in Myeloma More Effective with Pre and Post Add Ons, Wednesday, August 3, 5 pm EST
Wednesday, August 3, 2 pm PST, 3 pm MST, 4 pm CST, 5 pm EST…
Full Show: Nanotechnology in Multiple Myeloma with Dr. Samuel Achilefu, Dr. Ravi Vij and Dr. Monica Shokeen, Washington University
Dr. Samuel Achilefu PhD Dr. Ravi Vij, MD Dr. Monica Shokeen, PhD, MBA Washigton University…
Full Show: The Excitement Around Checkpoint Inhibitors in Myeloma with Dr. Don Benson, MD, PhD, Ohio State University
Dr. Don Benson, MD, PhD Ohio State University Interview Date: June 10, 2016 Summary Ten…
Our Next Show (Fri, June 10, 11A PST): The Excitement Around Checkpoint Inhibitors in Multiple Myeloma with Dr. Don Benson, MD, PhD, Ohio State University
Friday, June 10, 11 am PST, Noon MST, 1 pm CST, 2 pm EST Call…
Full Show: Should Costs be Controlled on the Way to a Cure for Multiple Myeloma? The ICER Report with President Dr. Steven Pearson
Dr. Steven Pearson, MD, MSc Institute for Clinical and Economic Review Interview Date: May 24,…
Our Next Show: ICER’s Value Recommendations Potential Impact on the Cost of New Drugs and Patient Access with Steven Pearson, MD, MSc, President of ICER on Tuesday, May 24 @ 11 am EST
Tuesday, May 24, 8 am PST, 9 am MST, 10 am CST, 11 am EST…
Full Show: The Importance of Proteasome Inhibitors in Myeloma and Their Evolution in the New Age of Myeloma Therapy with Dr. Jacob Laubach, MD, MPP, Dana Farber Cancer Institute
Dr. Jacob Laubach, MD, MPP Dana Farber Cancer Institute Interview Date: May 13, 2016 Summary…
Full Show: What Drives Myeloma Relapse? Myeloma Stem Cells May be the Cause with Dr. William Matsui, MD, Johns Hopkins School of Medicine
Dr. William Matsui, MD Johns Hopkins School of Medicine Interview Date: May 6, 2016 Summary…
Our Next Show: The Evolving Role of Proteasome Inhibitors in Today’s Myeloma Therapies with Dr. Jacob Laubach, MD, MPP, Dana Farber, Friday, May 13 @ 11 am EST
Friday, May 13, 8 am PST, 9 am MST, 10 am CST, 11 am EST…
Our Next Show: Killing Myeloma Stem Cells to Prevent Myeloma Progression Using a Monoclonal Antibody with Dr. William Matsui, Friday, May 6 @ 1 pm EST
Friday, May 6, 10 am PST, 11 am MST, Noon CST, 1 pm EST Call…
Full Show: The Road to Myeloma Recovery During and After Myeloma Treatment with Melanie House, DPT, NCS
Melanie J. House, DPT, NCS Clinical Specialist Department of Rehabilitation Therapies University of Iowa Hospitals…
Our Next Show: Overcoming Pain, Fatigue and Weakness During and After Myeloma Treatment, Tuesday, April 26 @ 1 pm CST
Tuesday, April 26 11 am PST, Noon MST, 1pm CST, 2 pm EST Call In…
Full Show: Not Giving Up on Treatment Options for Relapsed/Refractory Myeloma Patients with Dr. David Siegel, MD, PhD, John Theurer Cancer Center
Dr. David Siegel, MD, PhD John Theurer Cancer Center Interview Date: April 15, 2016 Summary…
Effective Combinations for Relapsed or Refractory Myeloma with Dr. David Siegel, MD, PhD, John Theurer Cancer Center, Friday, April 15 @ 10 am EST
Friday, April 15, 7 am PST, 8 am MST, 9 am CST, 10 am EST…
Full Show: Preventing Myeloma Before it Gets Started with Dr. Irene Ghobrial, MD, Dana Farber Cancer Institue
Dr. Irene Ghobrial, MD Dana Farber Cancer Institute / Harvard School of Medicine Interview Date:…
Full Show: Achieving Minimal Residual Disease with Myeloma Vaccines with Dr. David Avigan, MD Beth Israel Deaconess Medical Center
Dr. David Avigan, MD Beth Israel Deaconess Medical Center Interview Date: March 11, 2016 Summary…
Our Next Show: Myeloma Vaccines to Eliminate Minimal Residual Disease with Dr. David Avigan, MD, Beth Israel Deaconess Medical Center, Friday, March 11 @ 4 pm EST
Friday, March 11, 1 PST, 2 pm MST, 3 pm CST, 4 pm EST Call In by Phone to…